Publicaciones en las que colabora con Luis A. Moreno Aznar (19)

2022

  1. Determinants of Longitudinal Changes in Cardiometabolic Risk in Adolescents with Overweight/Obesity: The EVASYON Study

    Nutrients, Vol. 14, Núm. 15

2019

  1. Diet quality index as a predictor of treatment efficacy in overweight and obese adolescents: The EVASYON study

    Clinical Nutrition, Vol. 38, Núm. 2, pp. 782-790

2018

  1. Changes in plasma fatty acid composition are associated with improvements in obesity and related metabolic disorders: A therapeutic approach to overweight adolescents

    Clinical Nutrition, Vol. 37, Núm. 1, pp. 149-156

  2. Valoración del cambio de composición corporal en adolescentes con sobrepeso y obesidad incluidos en un tratamiento multidisciplinar: Estudio EVASYON

    Revista española de nutrición humana y dietética, Vol. 22, Núm. 1, pp. 25-27

2017

  1. Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity

    Journal of Nutrigenetics and Nutrigenomics, Vol. 10, Núm. 1-2, pp. 43-62

  2. Relation between plasma antioxidant vitamin levels, adiposity and cardio-metabolic profile in adolescents: Effects of a multidisciplinary obesity programme

    Clinical Nutrition, Vol. 36, Núm. 1, pp. 209-217

2016

  1. Behavioral predictors of attrition in adolescents participating in a multidisciplinary obesity treatment program: EVASYON study

    International Journal of Obesity, Vol. 40, Núm. 1, pp. 84-87

2015

  1. Anthropometric indices to assess body-fat changes during a multidisciplinary obesity treatment in adolescents: EVASYON Study

    Clinical Nutrition, Vol. 34, Núm. 3, pp. 523-528

  2. Cambios de composiciÓn corporal durante el tratamiento multidisciplinar en adolescentes obesos: Estudio Evasyon

    Nutricion Hospitalaria, Vol. 32, Núm. 6, pp. 2525-2534

2014

  1. Telomere length as a biomarker for adiposity changes after a multidisciplinary intervention in overweight/obese adolescents: The EVASYON study

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. Corrigendum: Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents (International Journal of Obesity, (2009), 33, 7, (758-767), 10.1038/ijo.2008.260)

    International Journal of Obesity

2011

  1. Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment program in overweight adolescents: Preliminary findings from the EVASYON study

    Pediatric Diabetes, Vol. 12, Núm. 4 PART 2, pp. 372-380

2009

  1. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. the EVASYON study

    BMC Public Health, Vol. 9

  2. IL6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors

    Journal of Physiology and Biochemistry, Vol. 65, Núm. 4, pp. 405-413

  3. Interplay between weight loss and gut microbiota composition in overweight adolescents

    Obesity, Vol. 17, Núm. 10, pp. 1906-1915

  4. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents

    International Journal of Obesity, Vol. 33, Núm. 7, pp. 758-767

2008

  1. Birth weight and blood lipid levels in Spanish adolescents: Influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study

    BMC Medical Genetics, Vol. 9

  2. Treatment of obesity in children and adolescents. How nutrition can work?

    International Journal of Pediatric Obesity, Vol. 3, Núm. SUPPL.1, pp. 72-77

2007

  1. Effect of the Ala12 allele in the PPARγ-2 gene on the relationship between birth weight and body composition in adolescents: The AVENA study

    Pediatric Research, Vol. 62, Núm. 5, pp. 615-619